Saturday 17 October 2026
Export NVNO’s income statement to Excel — free account
enVVeno Medical Corporation
NVNO Healthcare Medical Devices
In the quarter to June 2026, EPS grew 53.6% and free cash flow grew 4.60%, each against the same quarter a year earlier.
7.47
0.46
−5.80%
Follow NVNO
enVVeno Medical Corporation (NVNO) P/E ratio
enVVeno Medical Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2019 | 0.0× | — |
| Dec 2018 | 0.0× | — |
| Sep 2018 | 0.0× | — |
| Jun 2018 | 0.0× | — |
| 5 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| VNRX VolitionRX Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| INBS Intelligent Bio Solutions Inc. compare | n/m |
| TRIB Trinity Biotech PLC compare | n/m |
| VVOS Vivos Therapeutics, Inc. compare | n/m |
| NVNO enVVeno Medical Corporation | n/m |
| WOK WORK Medical Technology Group LTD compare | — |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)